Glen J. Weiss

First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas

Amita Patnaik, Leonard J. Appleman, Anthony W. Tolcher et al. · Annals of Oncology · 2016 · 236 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma

Donald W. Northfelt, Ramesh K. Ramanathan, Peter A. Cohen et al. · Clinical Cancer Research · 2014 · 68 citations

Medicine, Oncology, Pharmacology +16

Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma

Amita Patnaik, Glen J. Weiss, K. Papadopoulos et al. · British Journal of Cancer · 2014 · 47 citations · Full text

Medicine, Oncology, Pharmacology +15

A phase I dose-escalation study of NKP-1339 in patients with advanced solid tumors refractory to treatment.

Natalie R. Dickson, Suzanne F. Jones, H. A. Burris et al. · Journal of Clinical Oncology · 2011 · 34 citations

Medicine, Oncology, Pharmacology +7

Phase I Study of Intravenous PI3K Inhibitor Bay 80–6946: Preliminary Activity in Patients with Relapsed Non-Hodgkin Lymphoma (NHL) Treated in an MTD Expansion Cohort

Amita Patnaik, Ramesh K. Ramanathan, Leonard J. Appleman et al. · Blood · 2012 · 11 citations

Medicine, Oncology, Pharmacology +14